Searched for
TARGETED CANCER THERAPIES
GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concernsThe oral drug, pociredir, was being tested to treat sickle-cell disease, an inherited blood disorder that can trigger pain, anemia and or...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- She was dancing at an office party. Next day, doctors gave her a shocking diagnosis. Years of treatment, she lost her hair but found a fearless version of herselfAnvita Kamath, diagnosed with breast cancer at 28, faced a grueling treatment after discovering the disease had spread to her lymph nodes. ...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisitionZydus Lifesciences shares witnessed a spike on Thursday after the company said its board will meet on May 19 to consider a share buyback. T...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Experimental pancreatic cancer drug appears to dramatically improve one year survival ratesA groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...
- Kiran Mazumdar-Shaw picks niece Claire as successor at BioconBiocon's founder Kiran Mazumdar-Shaw has made a groundbreaking announcement, pledging her niece Claire Mazumdar as her heir apparent. The t...
- Netanyahu says he was successfully treated for prostate cancerIsraeli Prime Minister Benjamin Netanyahu announced successful treatment for early-stage prostate cancer. A routine checkup revealed a mali...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- 96.6% in CBSE class 10 despite cancer: Topper Aarav Vats’ unbelievable battle with Lymphoma will give you goosebumpsAarav Vats’ remarkable achievement of scoring 96.6% in the CBSE Class 10 examinations, despite battling Lymphoblastic Lymphoma for two year...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
- US stocks today: S&P, Nasdaq rise 1% as investors hold out hope for US-Iran resolutionUS stocks rose as investors weighed Middle East tensions and hopes of a potential resolution in the Iran conflict. Gains in tech stocks lif...
- Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
- Game-changing Cancer-killing molecule unveiled by scientists; targets tumors, spares healthy cellsIn a groundbreaking discovery, scientists at the City of Hope, a leading cancer research institute in the US, have developed a game-changin...
- IIT researchers find new molecule that can be used as targeted therapy to treat prostate cancerThe molecule has shown potency in cells to completely reduce tumour in 50 days.
Load More
